Cargando…
Neurotrophin Gene Therapy for Sustained Neural Preservation after Deafness
The cochlear implant provides auditory cues to profoundly deaf patients by electrically stimulating the residual spiral ganglion neurons. These neurons, however, undergo progressive degeneration after hearing loss, marked initially by peripheral fibre retraction and ultimately culminating in cell de...
Autores principales: | Atkinson, Patrick J., Wise, Andrew K., Flynn, Brianna O., Nayagam, Bryony A., Hume, Clifford R., O’Leary, Stephen J., Shepherd, Robert K., Richardson, Rachael T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524079/ https://www.ncbi.nlm.nih.gov/pubmed/23284995 http://dx.doi.org/10.1371/journal.pone.0052338 |
Ejemplares similares
-
Hair Cell Regeneration after ATOH1 Gene Therapy in the Cochlea of Profoundly Deaf Adult Guinea Pigs
por: Atkinson, Patrick J., et al.
Publicado: (2014) -
Viability of Long-Term Gene Therapy in the Cochlea
por: Atkinson, Patrick J., et al.
Publicado: (2014) -
A radiolabeled drug tracing method to study neurotrophin-3 retention and distribution in the cochlea after nano-based local delivery
por: Lam, Patrick, et al.
Publicado: (2020) -
Improved Auditory Nerve Survival with Nanoengineered Supraparticles for Neurotrophin Delivery into the Deafened Cochlea
por: Wise, Andrew K., et al.
Publicado: (2016) -
Neurotrophins Regulate Bone Marrow Stromal Cell IL-6 Expression through the MAPK Pathway
por: Rezaee, Fariba, et al.
Publicado: (2010)